Nayara secures backing for patient AI support

Patients’ questions do not stop when an appointment ends. Nayara is building software to help manage that gap.

What happened

Nayara closed a pre-seed funding round led by SFC Capital. The amount was not disclosed.

Its platform is designed to answer routine patient questions, provide check-ins and route concerns to the appropriate care team. The funding will support product development, clinical validation and commercial expansion.

Why it matters

Helping teams identify which requests need attention could make follow-up more manageable. That depends on accurate responses and dependable escalation, particularly when a patient describes something requiring clinical assessment.

The bigger picture

The intended use is patient support, rather than evidence that an AI system can replace a clinician. Clinical benefit and safety are not verified enough to claim from this funding announcement and require validation in the settings where the platform is used.